Clinical Pharmacokinetics of Quinidine
- 1 January 1980
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 5 (2), 150-168
- https://doi.org/10.2165/00003088-198005020-00003
Abstract
The elimination of quinidine is accomplished by a combination of renal excretion of the intact drug (15 to 40% of total clearance) and hepatic biotransformation to a variety of metabolites (60 to 85% of total clearance). Many of the metabolites appear to be pharmacologically active. Typical ranges for kinetic properites of quinidine in healthy persons are: apparent volume of distribution 2.0 to 3.5 litres/kg; elimination half-life 5 to 12 hours; clearance, 2.5 to 5.0 ml/min/kg. Quinidine clearance is reduced in the elderly, in patients with cirrhosis, and in those with congestive heart failure. Oral quinidine is available either as relatively rapidly absorbed conventional tablets (usually quinidine sulphate) or as a variety of slowly absorbed sustained release preparations. Absolute systemic availability generally is 70% or greater. Quinidine is 70 to 95% bound to plasma protein, primarily to albumin but also to a number of other plasma constituents. Binding is reduced in patients with cirrhosis, partly because of hypoalbuminaemia, but is not influenced by renal insufficiency. Clinical interpretation of total serum or plasma quinidine concentrations must be altered in patients with reduced or increased binding, since it is the unbound fraction which is pharmacologically active.Keywords
This publication has 86 references indexed in Scilit:
- Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humansAmerican Heart Journal, 1980
- The Quinidine-Digoxin InteractionNew England Journal of Medicine, 1979
- Quinidine-Digoxin InteractionNew England Journal of Medicine, 1979
- Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methodsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Digoxin-Quinidine InteractionNew England Journal of Medicine, 1979
- Relative Bioavailability of Quinidine Gluconate and Quinidine Sulfate in Healthy VolunteersThe Journal of Clinical Pharmacology, 1979
- Evaluation of Quinidine Lipettes®— a Sustained Release PreparationActa Medica Scandinavica, 1979
- Reduced quinidine clearance in elderly personsThe American Journal of Cardiology, 1978
- The effect of congestive heart failure on quinidine pharmacokineticsAmerican Heart Journal, 1975
- Relation between serum quinidine levels and renal function: Studies in normal subjects and patients with congestive failure and renal insufficiencyThe American Journal of Cardiology, 1971